US Patent Issued to Janssen Biotech on Sept. 29 for "Manufacturing methods for producing anti-IL12/IL23 antibody compositions" (Dutch, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,289, issued on Sept. 29, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Manufacturing methods for producing anti-IL12/IL23 antibody compositions" was invented by Kristopher Barnthouse (Pottstown, Pa.), Subinay Ganguly (Newtown, Pa.), Maarten Groeneveld (Oegstgeest, Netherlands), Manuel Lopez Jr. (Devon, Pa.), Michael Nedved (Downingtown, Pa.) and Kevin D. Smith (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of manufacture for producing anti-IL-12/IL-23p40 antibodies, e.g., the anti-IL-12/IL-23p40 antibody ustekinumab, in CHO and specific pharmaceutical compositions of the antibody are useful in treating various diseases...